Patent details

Basic Information

Publication number:

EP1343782

PCT Application Number:

PCT/US/2001/049367

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP019943158

PCT Publication Number:

WO/2002/059110

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PYRIMIDINEAMINES AS ANGIOGENESIS MODULATORS

French Title of Invention:

COMPOSES CHIMIQUES

German Title of Invention:

PYRIMIDINAMINE ALS ANGIOGENESEMODULATOREN

SPC Number:

91710

Dates

Filing date:

19/12/2001

Grant date:

06/05/2009

EP Publication Date:

06/05/2009

PCT Publication Date:

01/08/2002

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/09/2003

EP B1 Publication Date:

06/05/2009

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

19/12/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/12/2015

 

 

Name:

NOVARTIS AG

Address:

LICHTSTRASSE 35, 4056, BASEL, Switzerland (CH)

History of Owners

From:

17/12/2015

To:

17/12/2015

Name:

LEO OSPREY LIMITED

Address:

980 GREAT WEST ROAD, BRENTFORD, MIDDLESEX TW8 9GS, United Kingdom (GB)

From:

25/03/2010

To:

16/12/2015

Name:

GlaxoSmithKline LLC

Address:

One Franklin Plaza 200 North 16th Street, Philadelphia, PA 19102, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

27/05/2009

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

CHEUNG Mui GlaxoSmithKline

Address:

United States (US)

2

Name:

STAFFORD Jeffery, Alan GlaxoSmithKline

Address:

United States (US)

3

Name:

HARRIS Philip, Anthony GlaxoSmithKline

Address:

United States (US)

4

Name:

DAVIS Ronda GlaxoSmithKline

Address:

United States (US)

5

Name:

MOOK Robert, Anthony,Jr. GlaxoSmithKline

Address:

United States (US)

6

Name:

HINKLE Kevin GlaxoSmithKline

Address:

United States (US)

7

Name:

BOLOOR Amogh

Address:

United States (US)

8

Name:

VEAL James, Martin GlaxoSmithKline

Address:

United States (US)

Priority

1

Priority Number:

257526 P

Priority Date:

21/12/2000

Priority Country:

United States (US)

2

Priority Number:

262403 P

Priority Date:

16/01/2001

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 403/12;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

10/12/2020

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages